S&P 500   5,103.36 (-0.54%)
DOW   38,799.25 (-0.49%)
QQQ   439.36 (-1.05%)
AAPL   171.20 (-2.23%)
MSFT   409.95 (-1.20%)
META   492.85 (-1.07%)
GOOGL   132.83 (-0.39%)
AMZN   175.73 (-1.04%)
TSLA   182.76 (-2.86%)
NVDA   849.09 (-0.38%)
NIO   5.16 (-3.19%)
AMD   201.31 (-1.97%)
BABA   71.92 (-0.11%)
T   17.14 (+2.02%)
F   12.67 (-0.55%)
MU   94.95 (-0.86%)
CGC   2.96 (-1.99%)
GE   160.99 (-0.01%)
DIS   113.66 (-0.03%)
AMC   4.34 (+0.46%)
PFE   25.83 (-0.23%)
PYPL   60.30 (+0.53%)
XOM   104.89 (+0.51%)
S&P 500   5,103.36 (-0.54%)
DOW   38,799.25 (-0.49%)
QQQ   439.36 (-1.05%)
AAPL   171.20 (-2.23%)
MSFT   409.95 (-1.20%)
META   492.85 (-1.07%)
GOOGL   132.83 (-0.39%)
AMZN   175.73 (-1.04%)
TSLA   182.76 (-2.86%)
NVDA   849.09 (-0.38%)
NIO   5.16 (-3.19%)
AMD   201.31 (-1.97%)
BABA   71.92 (-0.11%)
T   17.14 (+2.02%)
F   12.67 (-0.55%)
MU   94.95 (-0.86%)
CGC   2.96 (-1.99%)
GE   160.99 (-0.01%)
DIS   113.66 (-0.03%)
AMC   4.34 (+0.46%)
PFE   25.83 (-0.23%)
PYPL   60.30 (+0.53%)
XOM   104.89 (+0.51%)
S&P 500   5,103.36 (-0.54%)
DOW   38,799.25 (-0.49%)
QQQ   439.36 (-1.05%)
AAPL   171.20 (-2.23%)
MSFT   409.95 (-1.20%)
META   492.85 (-1.07%)
GOOGL   132.83 (-0.39%)
AMZN   175.73 (-1.04%)
TSLA   182.76 (-2.86%)
NVDA   849.09 (-0.38%)
NIO   5.16 (-3.19%)
AMD   201.31 (-1.97%)
BABA   71.92 (-0.11%)
T   17.14 (+2.02%)
F   12.67 (-0.55%)
MU   94.95 (-0.86%)
CGC   2.96 (-1.99%)
GE   160.99 (-0.01%)
DIS   113.66 (-0.03%)
AMC   4.34 (+0.46%)
PFE   25.83 (-0.23%)
PYPL   60.30 (+0.53%)
XOM   104.89 (+0.51%)
S&P 500   5,103.36 (-0.54%)
DOW   38,799.25 (-0.49%)
QQQ   439.36 (-1.05%)
AAPL   171.20 (-2.23%)
MSFT   409.95 (-1.20%)
META   492.85 (-1.07%)
GOOGL   132.83 (-0.39%)
AMZN   175.73 (-1.04%)
TSLA   182.76 (-2.86%)
NVDA   849.09 (-0.38%)
NIO   5.16 (-3.19%)
AMD   201.31 (-1.97%)
BABA   71.92 (-0.11%)
T   17.14 (+2.02%)
F   12.67 (-0.55%)
MU   94.95 (-0.86%)
CGC   2.96 (-1.99%)
GE   160.99 (-0.01%)
DIS   113.66 (-0.03%)
AMC   4.34 (+0.46%)
PFE   25.83 (-0.23%)
PYPL   60.30 (+0.53%)
XOM   104.89 (+0.51%)
NASDAQ:NRC

National Research (NRC) Stock Price, News & Analysis

$40.20
-0.01 (-0.02%)
(As of 09:30 AM ET)
Today's Range
$40.20
$40.20
50-Day Range
$36.87
$41.20
52-Week Range
$36.21
$47.25
Volume
301 shs
Average Volume
86,030 shs
Market Capitalization
$987.31 million
P/E Ratio
32.16
Dividend Yield
1.19%
Price Target
N/A

National Research MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.04% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.71mentions of National Research in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$10.57 M Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.84 out of 5 stars

Business Services Sector

259th out of 316 stocks

Commercial Physical Research Industry

13th out of 13 stocks


NRC stock logo

About National Research Stock (NASDAQ:NRC)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, workforce engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

NRC Stock Price History

NRC Stock News Headlines

Detecting Cancer in Mere Seconds: Early Investment Opportunity
A revolutionary cancer diagnostic tool is likely to come to fruition with anticipated FDA approval expected in just months. With the ability to detect cancer's "molecular fingerprint" in just seconds, it also offers far superior accuracy to current detection methods and reduces the need for invasive biopsies.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
National Research Corporation (NRC)
National Research Corporation (NRC)
National Research Corp Class A
U.S. Nuclear Sector Set for Major Transformation
See More Headlines
Receive NRC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for National Research and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/11/2020
Ex-Dividend for 1/12 Dividend
12/28/2023
Dividend Payable
1/12/2024
Today
3/05/2024
Ex-Dividend for 4/15 Dividend
3/27/2024
Dividend Payable
4/15/2024
Next Earnings (Estimated)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Current Symbol
NASDAQ:NRC
Employees
491
Year Founded
1981

Profitability

Net Income
$30.97 million
Pretax Margin
26.90%

Debt

Sales & Book Value

Annual Sales
$148.58 million
Cash Flow
$1.49 per share
Book Value
$1.99 per share

Miscellaneous

Free Float
23,969,000
Market Cap
$987.56 million
Optionable
Optionable
Beta
0.42

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for March 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Michael D. Hays (Age 69)
    Founder, CEO, President & Director
    Comp: $131.65k
  • Mr. Kevin R. Karas CPA (Age 66)
    Senior VP of Finance, CFO, Treasurer & Secretary
    Comp: $292.81k
  • Ms. Helen L. Hrdy (Age 58)
    Chief Customer Officer
    Comp: $291.31k
  • Mr. Andy Monnich
    Chief Corporate Development Officer
  • Mr. Jon Boumstein
    Chief Delivery Officer
  • Dr. Gregory Makoul M.S.
    Ph.D., Chief Transformation Officer
  • Mr. Jason Hahn
    Chief Revenue Officer
  • Mr. Christophe Louvion
    Chief Product Technology Officer
  • Linda Stacy
    Vice President of Finance
  • Megan Charko
    Senior Manager of Content Marketing














NRC Stock Analysis - Frequently Asked Questions

How have NRC shares performed in 2024?

National Research's stock was trading at $39.56 at the beginning of the year. Since then, NRC shares have increased by 1.6% and is now trading at $40.21.
View the best growth stocks for 2024 here
.

When is National Research's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our NRC earnings forecast
.

How were National Research's earnings last quarter?

National Research Co. (NASDAQ:NRC) released its earnings results on Tuesday, February, 11th. The company reported $0.34 earnings per share (EPS) for the quarter. The business had revenue of $32.62 million for the quarter. National Research had a net margin of 20.84% and a trailing twelve-month return on equity of 47.79%.

How often does National Research pay dividends? What is the dividend yield for National Research?

National Research announced a quarterly dividend on Tuesday, February 13th. Stockholders of record on Friday, March 29th will be paid a dividend of $0.12 per share on Monday, April 15th. This represents a $0.48 annualized dividend and a yield of 1.19%. The ex-dividend date is Wednesday, March 27th.
Read our dividend analysis for NRC
.

Is National Research a good dividend stock?

National Research (NASDAQ:NRC) pays an annual dividend of $0.48 per share and currently has a dividend yield of 1.18%. The dividend payout ratio is 38.40%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for NRC.

What ETF holds National Research's stock ?

Small Cap US Equity Select ETF holds 16,946 shares of NRC stock, representing 2.76% of its portfolio.

What is Michael D. Hays' approval rating as National Research's CEO?

85 employees have rated National Research Chief Executive Officer Michael D. Hays on Glassdoor.com. Michael D. Hays has an approval rating of 87% among the company's employees.

What other stocks do shareholders of National Research own?

Based on aggregate information from My MarketBeat watchlists, some companies that other National Research investors own include Altria Group (MO), Enterprise Products Partners (EPD), AbbVie (ABBV), Dominion Energy (D), Gilead Sciences (GILD), Pfizer (PFE), Toronto-Dominion Bank (TD), Verizon Communications (VZ), Wells Fargo & Company (WFC) and TD Ameritrade (AMTD).

Who are National Research's major shareholders?

National Research's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (3.81%), Conestoga Capital Advisors LLC (3.18%), Dimensional Fund Advisors LP (2.59%), QV Investors Inc. (1.61%), Northern Trust Corp (1.12%) and Touchstone Capital Inc. (1.02%). Insiders that own company stock include Amandla Mk Trust, Jona S Raasch and Kevin R Karas.
View institutional ownership trends
.

How do I buy shares of National Research?

Shares of NRC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does National Research have any subsidiaries?
The following companies are subsidiares of National Research: National Research Corporation Canada, PatientWisdom Inc., and The Governance Institute.
Read More
This page (NASDAQ:NRC) was last updated on 3/5/2024 by MarketBeat.com Staff